NEURIMMUNE HOLDING AG innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	United States	17
#2	EPO (European Patent Office)	10
#3	China	9
#4	Israel	8
#5	Australia	7
#6	Canada	7
#7	WIPO (World Intellectual Property Organization)	7
#8	Japan	6
#9	Mexico	5
#10	Republic of Korea	4
#11	Brazil	3
#12	Singapore	3
#13	Hungary	2
#14	Serbia	2
#15	Hong Kong	1
#16	New Zealand	1
#17	Peru	1
#18	Philippines	1

#	Technology
#1	Medical preparations
#2	Peptides
#3	Therapeutic chemical compounds
#4	Analysing materials
#5	Microorganisms
#6	Measuring microorganism processes
#7	Enzymes
#8	Animal care
#9	Climate change adaptation technologies

Publication	Filing date	Title
SG11201701925XA	2015-09-30	Human-derived anti-dipeptide repeats (dprs) antibody
WO2016016278A2	2015-07-29	Human-derived anti-huntingtin (htt) antibodies and uses thereof
AU2015228818A1	2015-03-12	Novel compounds capable of antagonizing islet amyloid polypeptide (IAPP) induced beta-cell damage and impaired glucose tolerance
SG11201604831QA	2014-12-22	Antibody-based therapy of transthyretin (ttr) amyloidosis and human-derived antibodies therefor
EP2938631A1	2014-01-02	Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases
HUE040354T2	2013-09-12	Human islet amyloid polypeptide (hiapp) specific antibodies and uses thereof
CN112225808A	2013-09-12	Human islet amyloid polypeptide (HIAPP) specific antibodies and uses thereof
EP2651979A1	2011-12-19	Human anti-sod1 antibodies
EP2185160A2	2008-09-01	Method of providing patient specific immune response in amyloidoses and protein aggregation disorders